Apr 12, 2021
By: Rounak JainThe IT services giant is set to announce its March 2021 quarter earnings today.
Credit: IANS
The company’s board will meet on April 14 to consider a share buyback proposal.
Credit: IANS
LIC has increased its stake in the company from 4.02 percent to 4.8 percent as of the end of December 2020.
Credit: JSW-Steel
Its marketing and distribution partner Alvogen Pine Brook LLC has received tentative US FDA approval for Ibrutinib tablets.
Credit: Natco-Pharma
UTI Mutual Fund has increased its stake in the company by further acquiring 1.78 percent shares, taking its total shareholding to 5.02 percent.
Credit: BCCL
The company’s board has approved the amalgamation of Aurora Life Sciences, Empyrean Lifesciences and Hydra Active Pharma Sciences, subject to regulatory approval.
Credit: Solara-Active-Pharma
It has extended its partnership with Bahrain Internet Exchange to offer high-speed internet connectivity with capacity to scale beyond 100 Gbps.
Credit: Tata-Communications
The company confirmed at its AGM that it is on track to expand its capacity to 50 metric tonnes per annum.
Credit: Ambuja-Cements
It has revised the capex for 320 KLPD distillery plant from ₹325 crore to ₹420 crore, which could generate up to ₹650 crore in annual revenue when it becomes operational.
Credit: Unsplash
Gilead has signed licensing agreements with Indian pharma companies, including Cipla, Dr. Reddy’s Laboratories, Jubilant Life Sciences and others to manufacture Remdesivir.
Credit: BCCL